Bei grossen Gesetzen wie OR und ZGB kann dies bis zu 30 Sekunden dauern

Federal Act
on Research involving Human Beings
(Human Research Act, HRA)

English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force.

of 30 September 2011 (Status as of 26 May 2021)

The Federal Assembly of the Swiss Confederation,

on the basis of Article 118b paragraph 1 of the Federal Constitution1,
and having considered the Dispatch of the Federal Council dated 21 October 20092,

decrees:

Chapter 1 General Provisions

Section 1 Purpose, Scope and Definitions

Art. 1 Purpose  

1 The pur­pose of this Act is to pro­tect the dig­nity, pri­vacy and health of hu­man be­ings in­volved in re­search.

2 It is also de­signed to:

a.
cre­ate fa­vour­able con­di­tions for re­search in­volving hu­man be­ings;
b.
help to en­sure the qual­ity of re­search in­volving hu­man be­ings;
c.
en­sure the trans­par­ency of re­search in­volving hu­man be­ings.
Art. 2 Scope  

1 This Act ap­plies to re­search con­cern­ing hu­man dis­eases and con­cern­ing the struc­ture and func­tion of the hu­man body, which in­volves:

a.
per­sons;
b.
de­ceased per­sons;
c.
em­bry­os and foetuses;
d.
bio­lo­gic­al ma­ter­i­al;
e.
health-re­lated per­son­al data.

2 It does not ap­ply to re­search which in­volves:

a.
IVF em­bry­os in ac­cord­ance with the Stem Cell Re­search Act of 19 Decem­ber 20033;
b.
an­onymised bio­lo­gic­al ma­ter­i­al;
c.
an­onym­ously col­lec­ted or an­onymised health-re­lated data.
Art. 3 Definitions  

In this Act:

a.
Re­search means meth­od-driv­en search for gen­er­al­is­able know­ledge;
b.
Re­search con­cern­ing dis­eases means re­search on the causes, pre­ven­tion, dia­gnos­is, treat­ment and epi­demi­ology of impair­ments of phys­ic­al and men­tal health in hu­man be­ings;
c.
Re­search con­cern­ing the struc­ture and func­tion of the hu­man body means ba­sic re­search, in par­tic­u­lar on hu­man ana­tomy, physiology and ge­net­ics, and non-dis­ease-re­lated re­search con­cern­ing in­ter­ven­tions and im­pacts on the hu­man body;
d.
Re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit means a re­search pro­ject whose res­ults can be ex­pec­ted to im­prove the health of the par­ti­cipants;
e.
Bio­lo­gic­al ma­ter­i­al means bod­ily sub­stances de­rived from liv­ing per­sons;
f.
Health-re­lated per­son­al data means in­form­a­tion con­cern­ing the health or dis­ease of a spe­cif­ic or iden­ti­fi­able per­son, in­clud­ing ge­net­ic data;
g.
Ge­net­ic data means in­form­a­tion on a per­son's genes, ob­tained by ge­net­ic test­ing;
h.
Coded bio­lo­gic­al ma­ter­i­al and coded health-re­lated per­son­al data meansbio­lo­gic­al ma­ter­i­al and data linked to a spe­cif­ic per­son via a code;
i.
An­onymised bio­lo­gic­al ma­ter­i­al and an­onymised health-re­lated data meansbio­lo­gic­al ma­ter­i­al and health-re­lated data which can­not (without dis­pro­por­tion­ate ef­fort) be traced to a spe­cif­ic per­son;
j.
Child means a leg­al minor un­der 14 years of age;
k.
Ad­oles­cent means a leg­al minor aged 14 years or more;
l.4
...

4 Re­pealed by An­nex of the FA of 22 March 2019, with ef­fect from 26 May 2021 (AS 2020 2961; BBl 2019 1).

Section 2 Principles

Art. 4 Primacy of individual interests  

The in­terests, health and wel­fare of the in­di­vidu­al hu­man be­ing shall pre­vail over the in­terests of sci­ence and so­ci­ety.

Art. 5 Scientifically relevant topic  

Re­search in­volving hu­man be­ings may only be car­ried out if it ad­dresses a top­ic of sci­entif­ic rel­ev­ance con­cern­ing:

the un­der­stand­ing of hu­man dis­eases;
the struc­ture and func­tion of the hu­man body; or
pub­lic health.
Art. 6 Non-discrimination  

1 Nobody is to be sub­jec­ted to dis­crim­in­a­tion in con­nec­tion with re­search.

2 With re­gard to the se­lec­tion of par­ti­cipants in par­tic­u­lar, no group of per­sons shall be dis­pro­por­tion­ately in­cluded in or ex­cluded from re­search without good reas­on.

Art. 7 Consent  

1 Re­search in­volving hu­man be­ings may only be car­ried out if, in ac­cord­ance with the pro­vi­sions of this Act, the per­sons con­cerned have giv­en their in­formed con­sent or, after be­ing duly in­formed, have not ex­er­cised their right to dis­sent.

2 The per­sons con­cerned may with­hold or re­voke their con­sent at any time, without stat­ing their reas­ons.

Art. 8 Right to receive information  

1 The per­sons con­cerned are en­titled to be in­formed of res­ults re­lat­ing to their health. The in­form­a­tion is to be com­mu­nic­ated in an ap­pro­pri­ate man­ner. The per­sons con­cerned may choose to forgo such in­form­a­tion.

2 They are en­titled to be in­formed about all the per­son­al data held in re­la­tion to them.

Art. 9 Prohibition of commercialisation 5  

1 It is pro­hib­ited to of­fer, grant, de­mand or ac­cept pay­ment or any oth­er non-cash ad­vant­age in ex­change for the hu­man body or parts there­of as such.

2 It is also pro­hib­ited to use the hu­man body or parts there­of if they have been sub­ject to a pro­hib­ited act as spe­cified in para­graph 1.

5 Amended by An­nex No 2 of the FD of 19 June 2020 on the Ap­prov­al of the Coun­cil of Europe Con­ven­tion against Traf­fick­ing in Hu­man Or­gans and on its Im­ple­ment­a­tion, in force since 1 Feb. 2021 (AS 2020 6567; BBl 2019 5971).

Art. 10 Scientific requirements  

1 Re­search in­volving hu­man be­ings may only be car­ried out if:

a.
the re­cog­nised reg­u­la­tions con­cern­ing sci­entif­ic in­teg­rity are com­plied with, in par­tic­u­lar with re­gard to the hand­ling of con­flicts of in­terest;
b.
sci­entif­ic qual­ity re­quire­ments are met;
c.
the re­cog­nised in­ter­na­tion­al Good Prac­tice guidelines for re­search in­volving hu­man be­ings are com­plied with; and
d.
the per­sons re­spons­ible have ap­pro­pri­ate pro­fes­sion­al qual­i­fic­a­tions.

2 The Fed­er­al Coun­cil shall spe­cify which na­tion­al and in­ter­na­tion­al reg­u­la­tions must be com­plied with.

Chapter 2 General Requirements for Research involving Persons

Section 1 Protection of Participants

Art. 11 Subsidiarity  

1 A re­search pro­ject in­volving per­sons may only be car­ried out if equi­val­ent find­ings can­not be ob­tained by oth­er means.

2 A re­search pro­ject in­volving par­tic­u­larly vul­ner­able per­sons may only be car­ried out if equi­val­ent find­ings can­not be ob­tained by oth­er means.

Art. 12 Risks and burdens  

1 In every re­search pro­ject, the risks and bur­dens for the par­ti­cipants must be min­im­ised as far as pos­sible.

2 The likely risks and bur­dens for the par­ti­cipants must not be dis­pro­por­tion­ate to the ex­pec­ted be­ne­fits of the re­search pro­ject.

Art. 13 Placebo  

In re­search pro­jects with an ex­pec­ted dir­ect be­ne­fit, the use of a placebo or non‑treat­ment is only per­miss­ible if no ad­di­tion­al risk of ser­i­ous or ir­re­vers­ible harm is to be ex­pec­ted for the per­sons con­cerned and:

no stand­ard treat­ment is avail­able; or
the use of a placebo is re­quired for com­pel­ling, sci­en­tific­ally sound meth­od­o­lo­gic­al reas­ons, in or­der to es­tab­lish the ef­fic­acy or safety of a treat­ment meth­od.
Art. 14 Non-remunerative participation  

1 No per­son may re­ceive pay­ment or any oth­er non-cash ad­vant­age for par­ti­cip­a­tion in a re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit. Par­ti­cip­a­tion in a re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit may be ap­pro­pri­ately re­mu­ner­ated.

2 No per­son may de­mand or ac­cept pay­ment or any oth­er non-cash ad­vant­age from an­oth­er in re­turn for the lat­ter’s par­ti­cip­a­tion in a re­search pro­ject.

Art.15 Safety and protective measures  

1 Any­one who con­ducts a re­search pro­ject must, be­fore it be­gins, take all the meas­ures re­quired to pro­tect the par­ti­cipants.

2 If, dur­ing the re­search pro­ject, cir­cum­stances arise which could jeop­ard­ise the safety or health of the par­ti­cipants or lead to a dis­pro­por­tion­ate re­la­tion­ship between the risks and bur­dens and the be­ne­fits, all the meas­ures re­quired to en­sure pro­tec­tion are to be taken without delay.

Section 2 Information and Consent

Art. 16 Informed consent  

1 Per­sons may only be in­volved in a re­search pro­ject if they have giv­en their in­formed con­sent. Con­sent must be giv­en in writ­ing; the Fed­er­al Coun­cil may spe­cify ex­emp­tions.

2 The per­sons con­cerned must re­ceive com­pre­hens­ible or­al and writ­ten in­form­a­tion on:

a.
the nature, pur­pose and dur­a­tion of, and pro­ced­ure for, the re­search pro­ject;
b.
the fore­see­able risks and bur­dens;
c.
the ex­pec­ted be­ne­fits of the re­search pro­ject, in par­tic­u­lar for them­selves or for oth­er people;
d.
the meas­ures taken to pro­tect the per­son­al data col­lec­ted;
e.
their rights.

3 Be­fore a de­cision on con­sent is made by the per­sons con­cerned, they must be al­lowed an ap­pro­pri­ate peri­od for re­flec­tion.

4 The Fed­er­al Coun­cil may spe­cify fur­ther ele­ments of the in­form­a­tion to be provided.

Art. 17 Consent to further use for research  

If the in­ten­tion ex­ists to make fur­ther use for re­search of bio­lo­gic­al ma­ter­i­al sampled or health-re­lated per­son­al data col­lec­ted, the con­sent of the per­sons con­cerned must be ob­tained at the time of such sampling or col­lec­tion, or they must be in­formed of their right to dis­sent.

Art. 18 Incomplete information  

1 In ex­cep­tion­al cases, the per­sons con­cerned may be giv­en in­com­plete in­form­a­tion re­gard­ing in­di­vidu­al as­pects of a re­search pro­ject be­fore it be­gins:

a.
in­so­far as this is es­sen­tial for meth­od­o­lo­gic­al reas­ons; and
b.
if the re­search pro­ject en­tails no more than min­im­al risks and bur­dens.

2 The par­ti­cipants must sub­sequently be duly in­formed as soon as pos­sible.

3 Once they have been in­formed in ac­cord­ance with para­graph 2, they may give or with­hold their con­sent to the use of their bio­lo­gic­al ma­ter­i­al or their data. Only when such con­sent has been giv­en is the bio­lo­gic­al ma­ter­i­al or data to be used for the re­search pro­ject.

Section 3 Liability and Coverage

Art. 19 Liability  

1 Any per­son who car­ries out a re­search pro­ject in­volving per­sons shall be li­able for dam­age suffered by them in con­nec­tion with the pro­ject. The Fed­er­al Coun­cil may spe­cify ex­emp­tions from li­ab­il­ity.

2 Com­pens­a­tion claims pre­scribe in ac­cord­ance with Art­icle 60 of the Swiss Code of Ob­lig­a­tions.6 The Fed­er­al Coun­cil may spe­cify a longer pre­script­ive peri­od for par­tic­u­lar re­search areas.7

3 The pro­vi­sions of the Code of Ob­lig­a­tions on tort are oth­er­wise ap­plic­able; in the ex­er­cise of of­fi­cial du­ties, the Gov­ern­ment Li­ab­il­ity Act of 14 March 19588, or can­ton­al gov­ern­ment li­ab­il­ity law, is ap­plic­able.

6 SR 220

7 Amended by An­nex No 17 of the FA of 15 June 2018 (Re­vi­sion of the Law on Pre­scrip­tion), in force since 1 Jan. 2020 (AS 2018 5343; BBl 2014 235).

8 SR 170.32

Art. 20 Coverage  

1 Li­ab­il­ity must be ap­pro­pri­ately covered through in­sur­ance or in some oth­er man­ner. The Fed­er­al Gov­ern­ment and its pub­lic-law in­sti­tu­tions and cor­por­a­tions are ex­empt from the li­ab­il­ity cov­er­age re­quire­ments.

2 The Fed­er­al Coun­cil may:

a.
spe­cify re­quire­ments for in­sur­ance and oth­er forms of cov­er­age;
b.
ex­empt re­search areas or classes of dam­age from the li­ab­il­ity cov­er­age re­quire­ments.

3 For the pro­tec­tion of the in­jured party, it may:

a.
grant this party a dir­ect claim against the party provid­ing li­ab­il­ity cov­er­age;
b.
re­strict the can­cel­la­tion rights and ob­jec­tions of the party provid­ing li­ab­il­ity cov­er­age, while grant­ing ap­pro­pri­ate rights of re­course.

Chapter 3 Additional Requirements for Research involving Particularly Vulnerable Persons

Section 1 Research involving Children, Adolescents and Adults lacking Capacity

Art. 21 Involvement of persons lacking capacity in the consent procedure  

1 Chil­dren, ad­oles­cents and adults lack­ing ca­pa­city must be in­volved as far as pos­sible in the con­sent pro­ced­ure.

2 In­creas­ing weight must be ac­cor­ded to the views of chil­dren and ad­oles­cents lack­ing ca­pa­city the older and more ma­ture they are.

Art. 22 Research projects involving children  

1 A re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit may only be car­ried out in chil­dren who are cap­able of judge­ment if:

a.
the child has giv­en in­formed con­sent; and
b.
the leg­al rep­res­ent­at­ive has giv­en in­formed con­sent in writ­ing.

2 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit may only be car­ried out in chil­dren who are cap­able of judge­ment if, in ad­di­tion to para­graph 1:

a.
it en­tails no more than min­im­al risks and bur­dens; and
b.
it can be ex­pec­ted to yield sub­stan­tial find­ings which could in the long term be be­ne­fi­cial for per­sons with the same dis­ease or dis­order, or in the same situ­ation.

3 A re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit may only be car­ried out in chil­dren who lack ca­pa­city if:

a.
the leg­al rep­res­ent­at­ive has giv­en in­formed con­sent in writ­ing; and
b.
the child does not vis­ibly ex­press op­pos­i­tion to the re­search in­ter­ven­tion either verbally or by his or her be­ha­viour.

4 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit may only be car­ried out in chil­dren who lack ca­pa­city if the re­quire­ments spe­cified in para­graphs 2 and 3 are met.

Art. 23 Research projects involving adolescents  

1 A re­search pro­ject with or without an ex­pec­ted dir­ect be­ne­fit may only be car­ried out in ad­oles­cents who are cap­able of judge­ment if:

a.
the ad­oles­cent has giv­en in­formed con­sent in writ­ing; and
b.
the leg­al rep­res­ent­at­ive has giv­en in­formed con­sent in writ­ing if the re­search pro­ject en­tails more than min­im­al risks and bur­dens.

2 A re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit may only be car­ried out in ad­oles­cents who lack ca­pa­city if:

a.
the leg­al rep­res­ent­at­ive has giv­en in­formed con­sent in writ­ing; and
b.
the ad­oles­cent does not vis­ibly ex­press op­pos­i­tion to the re­search in­ter­ven­tion either verbally or by his or her be­ha­viour.

3 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit may only be car­ried out in ad­oles­cents who lack ca­pa­city if, in ad­di­tion to the re­quire­ments spe­cified in para­graph 2:

a.
it en­tails no more than min­im­al risks and bur­dens; and
b.
it can be ex­pec­ted to yield sub­stan­tial find­ings which could in the long term be be­ne­fi­cial for per­sons with the same dis­ease or dis­order, or in the same situ­ation.
Art. 24 Research projects involving adults lacking capacity  

1 A re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit may only be car­ried out in adults who lack ca­pa­city if:

a.
this is per­mit­ted by the con­sent of the per­son con­cerned, gran­ted while in a state of ca­pa­city and duly doc­u­mented;
b.
in­formed con­sent has been giv­en in writ­ing by the leg­al rep­res­ent­at­ive, a des­ig­nated trus­ted per­son or the next of kin, if no doc­u­mented con­sent is avail­able; and
c.
the per­son con­cerned does not vis­ibly ex­press op­pos­i­tion to the re­search in­ter­ven­tion either verbally or by his or her be­ha­viour.

2 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit may only to be car­ried out in adults who lack ca­pa­city if, in ad­di­tion to the re­quire­ments spe­cified in para­graph 1:

a.
it en­tails no more than min­im­al risks and bur­dens; and
b.
it can be ex­pec­ted to yield sub­stan­tial find­ings which could in the long term be be­ne­fi­cial for per­sons with the same dis­ease or dis­order, or in the same situ­ation.

Section 2 Research involving Pregnant Women and Embryos and Foetuses in vivo

Art. 25 Prohibited research projects  

Re­search pro­jects de­signed to modi­fy prop­er­ties of an em­bryo or foetus for non‑dis­ease-re­lated reas­ons are pro­hib­ited.

Art. 26 Research projects involving pregnant women and embryos and foetuses in vivo  

1 A re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit for a preg­nant wo­man or for an em­bryo or foetus may only be car­ried out if the fore­see­able risks and bur­dens, both for the preg­nant wo­man and for the em­bryo or foetus, are not dis­pro­por­tion­ate to the ex­pec­ted be­ne­fits.

2 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit for the preg­nant wo­man or for the em­bryo or foetus may only be car­ried out if:

a.
it en­tails no more than min­im­al risks and bur­dens for the em­bryo or foetus; and
b.
it can be ex­pec­ted to yield sub­stan­tial find­ings which could in the long term be be­ne­fi­cial for preg­nant wo­men or for em­bry­os or foetuses.
Art. 27 Research projects concerning methods of induced abortion  

1 A preg­nant wo­man may only be asked wheth­er she wishes to par­ti­cip­ate in a re­search pro­ject con­cern­ing meth­ods of in­duced abor­tion after she has de­cided to un­der­go an abor­tion.

2 Art­icle 26 does not ap­ply.

Section 3 Research involving Prisoners

Art. 28 Research projects involving prisoners  

1 For re­search pro­jects with an ex­pec­ted dir­ect be­ne­fit which in­volve pris­on­ers, the gen­er­al re­quire­ments for re­search in­volving per­sons ap­ply; however, Art­icle 11 para­graph 2 does not ap­ply.

2 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit which in­volves pris­on­ers may only be car­ried out if it en­tails no more than min­im­al risks and bur­dens.

Art. 29 Prohibition of a relaxation of conditions  

Par­ti­cip­a­tion in a re­search pro­ject must not be as­so­ci­ated with re­lax­ing the con­di­tions of im­pris­on­ment.

Section 4 Research in Emergency Situations

Art. 30 Research projects in emergency situations  

1 A re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit may be car­ried out in emer­gency situ­ations if:

a.
the ne­ces­sary meas­ures have been taken so that the wishes of the per­son con­cerned can be de­term­ined as soon as pos­sible;
b.
the per­son con­cerned does not vis­ibly ex­press op­pos­i­tion to the re­search in­ter­ven­tion through either verbally or by his or her be­ha­viour; and
c.
a phys­i­cian who is not par­ti­cip­at­ing in the re­search pro­ject is called in to safe­guard the in­terests of the per­son con­cerned be­fore he or she is in­volved in the pro­ject; in ex­cep­tion­al cases, where there are good reas­ons for do­ing so, the phys­i­cian may be called in at a later stage.

2 A re­search pro­ject with no ex­pec­ted dir­ect be­ne­fit may be car­ried out in emer­gency situ­ations if, in ad­di­tion to the re­quire­ments spe­cified in para­graph 1:

a.
it en­tails no more than min­im­al risks and bur­dens; and
b.
it can be ex­pec­ted to yield sub­stan­tial find­ings which could in the long term be be­ne­fi­cial for per­sons with the same dis­ease or dis­order, or in the same situ­ation.
Art. 31 Post hoc or proxy consent  

1 The per­son con­cerned must be duly in­formed about the re­search pro­ject as soon as this be­comes pos­sible. He or she may sub­sequently give or with­hold con­sent.

2 If the per­son con­cerned re­fuses to give post hoc con­sent, the bio­lo­gic­al ma­ter­i­al and data may no longer be used for the re­search pro­ject.

3 The Fed­er­al Coun­cil shall spe­cify the pro­ced­ure for the pro­cure­ment of post hoc or proxy con­sent, in par­tic­u­lar with re­gard to the in­volve­ment of chil­dren, ad­oles­cents and adults lack­ing ca­pa­city.

Chapter 4 Further Use of Biological Material and Health-Related Personal Data for Research

Art. 32 Further use of biological material and genetic data  

1 Fur­ther use may be made of bio­lo­gic­al ma­ter­i­al and ge­net­ic data in un­coded form for a re­search pro­ject if in­formed con­sent has been giv­en by the per­son con­cerned, or by the leg­al rep­res­ent­at­ive or next of kin. For con­sent, Art­icles 16 and 22–24 ap­ply mu­tatis mutandis.

2 Fur­ther use may be made of bio­lo­gic­al ma­ter­i­al and ge­net­ic data in coded form for re­search pur­poses if in­formed con­sent has been giv­en by the per­son con­cerned, or by the leg­al rep­res­ent­at­ive or next of kin. For con­sent, Art­icles 16 and 22–24 ap­ply mu­tatis mutandis.

3 Bio­lo­gic­al ma­ter­i­al and ge­net­ic data may be an­onymised for re­search pur­poses if the per­son con­cerned or the leg­al rep­res­ent­at­ive or next of kin have been in­formed in ad­vance and have not dis­sen­ted to an­onymisa­tion. For dis­sent, Art­icles 22–24 ap­ply mu­tatis mutandis.

Art. 33 Further use of non-genetic health-related personal data  

1 Fur­ther use may be made of non-ge­net­ic health-re­lated per­son­al data in un­coded form for re­search pur­poses if in­formed con­sent has been giv­en by the per­son con­cerned, or by the leg­al rep­res­ent­at­ive or next of kin. For con­sent, Art­icles 16 and 22–24 ap­ply mu­tatis mutandis.

2 Fur­ther use may be made of non-ge­net­ic health-re­lated per­son­al data in coded form for re­search pur­poses if the per­son con­cerned or the leg­al rep­res­ent­at­ive or next of kin have been in­formed in ad­vance and have not dis­sen­ted. For dis­sent, Art­icles 22–24 ap­ply mu­tatis mutandis.

Art. 34 Absence of informed consent  

If the re­quire­ments for in­formed con­sent spe­cified in Art­icles 32 and 33 are not met, fur­ther use may be made of bio­lo­gic­al ma­ter­i­al or health-re­lated per­son­al data for re­search pur­poses in ex­cep­tion­al cases if:

a.
it is im­possible or dis­pro­por­tion­ately dif­fi­cult to ob­tain con­sent or to provide in­form­a­tion on the right to dis­sent, or this would im­pose an un­due bur­den on the per­son con­cerned;
b.
no doc­u­mented re­fus­al is avail­able; and
c.
the in­terests of re­search out­weigh the in­terests of the per­son con­cerned in de­cid­ing on the fur­ther use of his or her bio­lo­gic­al ma­ter­i­al and data.
Art. 35 Anonymisation and coding  

The Fed­er­al Coun­cil shall spe­cify the re­quire­ments for cor­rect and se­cure an­onymisa­tion and cod­ing and also the con­di­tions for break­ing the code.

Chapter 5 Research involving Deceased Persons

Art. 36 Consent  

1 Re­search may be car­ried out in de­ceased per­sons if, be­fore their death, the per­sons con­cerned con­sen­ted to the use of their body for re­search pur­poses.

2 If no doc­u­mented con­sent or re­fus­al of the de­ceased per­son is avail­able, the body or parts there­of may be used for re­search pur­poses if con­sent is giv­en by the next of kin or by a trus­ted per­son des­ig­nated dur­ing the life­time of the de­ceased per­son.

3 The con­sent of the next of kin or the trus­ted per­son is gov­erned by Art­icle 8 of the Trans­plant­a­tion Act of 8 Oc­to­ber 20049.

4 In the case of de­ceased per­sons whose death oc­curred more than 70 years pre­vi­ously, re­search may be car­ried out without con­sent be­ing giv­en as spe­cified in para­graph 2. If such re­search is op­posed by the next of kin, it may not be car­ried out.

Art. 37 Additional requirements  

1 A re­search pro­ject may be car­ried out in de­ceased per­sons when their death has been de­term­ined.

2 A re­search pro­ject may be car­ried out in de­ceased per­sons un­der­go­ing ar­ti­fi­cial res­pir­a­tion if, in ad­di­tion to the re­quire­ment spe­cified in para­graph 1, equi­val­ent find­ings can­not be ob­tained with de­ceased per­sons not un­der­go­ing ar­ti­fi­cial res­pir­a­tion. The Fed­er­al Coun­cil may spe­cify fur­ther con­di­tions.

3 Any­one who car­ries out a re­search pro­ject in ac­cord­ance with para­graph 2 must not have been in­volved in the de­term­in­a­tion of death or be au­thor­ised to is­sue in­struc­tions to the per­sons in­volved in this pro­ced­ure.

Art. 38 Research in connection with an autopsy or transplantation  

Small quant­it­ies of bod­ily sub­stances re­moved in the course of an autopsy or trans­plant­a­tion may be an­onymised for re­search pur­poses without con­sent, in the ab­sence of a doc­u­mented re­fus­al of the de­ceased per­son.

Chapter 6 Research involving Embryos and Foetuses from Induced Abortions and from Spontaneous Abortions including Stillbirths

Art. 39 Requirements for research in embryos and foetuses from induced abortions  

1 A preg­nant wo­man may only be asked wheth­er she wishes to make her em­bryo or foetus avail­able for re­search pur­poses after she has de­cided to un­der­go an abor­tion. For con­sent, Art­icles 16 and 22–24 ap­ply mu­tatis mutandis.

2 The time and meth­od of in­duced abor­tion must be chosen without re­gard to the re­search pro­ject.

3 Em­bry­os and foetuses from in­duced abor­tions may be used for a re­search pro­ject when death has been de­term­ined.

4 Any­one who car­ries out a re­search pro­ject in ac­cord­ance with para­graph 3 must not be in­volved in the abor­tion or be au­thor­ised to is­sue in­struc­tions to the per­sons in­volved in this pro­ced­ure.

Art. 40 Requirements for research in embryos and foetuses from spontaneous abortions including stillbirths  

1 Em­bry­os and foetuses from spon­tan­eous abor­tions in­clud­ing still­births may only be used for re­search pur­poses with the con­sent of the couple con­cerned. For con­sent, Art­icle 16 ap­plies mu­tatis mutandis.

2 Em­bry­os and foetuses from spon­tan­eous abor­tions may be used for a re­search pro­ject when death has been de­term­ined.

Chapter 7 Transfer, Export and Storage

Art. 41 Transfer for purposes other than research  

Bio­lo­gic­al ma­ter­i­al or health-re­lated per­son­al data which has been sampled or col­lec­ted or of which fur­ther use has been made for re­search pur­poses may only be passed on for pur­poses oth­er than re­search if:

a.
a leg­al basis ex­ists for such a trans­fer; or
b.
in the par­tic­u­lar case, in­formed con­sent to the trans­fer has been giv­en by the per­son con­cerned.
Art. 42 Export  

1 Bio­lo­gic­al ma­ter­i­al or ge­net­ic data may be ex­por­ted for re­search pur­poses if in­formed con­sent has been giv­en by the per­son con­cerned. For con­sent, Art­icles 16 and 22–24 and 32 ap­ply mu­tatis mutandis.

2 Non-ge­net­ic health-re­lated per­son­al data may be dis­closed abroad for re­search pur­poses if the re­quire­ments spe­cified in Art­icle 6 of the Fed­er­al Act of 19 June 199210 on Data Pro­tec­tion are met.

Art. 43 Storage  

1 Any­one who stores bio­lo­gic­al ma­ter­i­al or health-re­lated per­son­al data for re­search pur­poses must take ap­pro­pri­ate tech­nic­al and or­gan­isa­tion­al meas­ures to pre­vent un­au­thor­ised use there­of, and ful­fil the op­er­a­tion­al and pro­fes­sion­al re­quire­ments.

2 The Fed­er­al Coun­cil shall spe­cify the re­quire­ments for stor­age.

Art. 44 Deceased persons, embryos and foetuses including stillbirths  

Art­icles 41–43 ap­ply mu­tatis mutandis to de­ceased per­sons, to em­bry­os and foetuses in­clud­ing still­births and parts there­of, and to data col­lec­ted in this con­nec­tion.

Chapter 8 Authorisation, Notifications and Procedure

Art. 45 Mandatory authorisation  

1 Au­thor­isa­tion from the re­spons­ible eth­ics com­mit­tee is re­quired for:

a.
con­duct­ing a re­search pro­ject; or
b.
mak­ing fur­ther use of bio­lo­gic­al ma­ter­i­al or health-re­lated per­son­al data for re­search pur­poses in cases where con­sent has not been ob­tained or in­form­a­tion on the right to dis­sent has not been provided (Art. 34).

2 Au­thor­isa­tion is gran­ted if the eth­ic­al, leg­al and sci­entif­ic re­quire­ments of this Act are met. The de­cision must be avail­able with­in two months of sub­mis­sion of the ap­plic­a­tion. The Fed­er­al Coun­cil may:

a.
spe­cify short­er, risk-ad­ap­ted max­im­um lim­its for pro­cessing peri­ods;
b.
ad­just the pro­cessing peri­ods, if this is re­quired by re­cog­nised in­ter­na­tion­al reg­u­la­tions.11

3 The Fed­er­al Coun­cil may make changes to re­search pro­jects sub­ject to au­thor­isa­tion. In do­ing so, it shall have re­gard to re­cog­nised in­ter­na­tion­al reg­u­la­tions.

11 Amended by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Art. 46 Notification and information requirements  

1 The Fed­er­al Coun­cil may spe­cify no­ti­fic­a­tion or in­form­a­tion re­quire­ments, in par­tic­u­lar with re­gard to:

a.
the com­ple­tion or dis­con­tinu­ation of a re­search pro­ject;
b.
ad­verse events ob­served in con­nec­tion with a re­search pro­ject;
c.
the oc­cur­rence of cir­cum­stances dur­ing the con­duct of a re­search pro­ject which could af­fect the safety or health of the par­ti­cipants.

2 In do­ing so, it shall have re­gard to re­cog­nised in­ter­na­tion­al reg­u­la­tions.

Art. 47 Responsible ethics committee  

1 The re­spons­ible eth­ics com­mit­tee is that of the can­ton in whose ter­rit­ory the re­search is con­duc­ted.

2 If a re­search pro­ject is car­ried out ac­cord­ing to a stand­ard pro­tocol, but in dif­fer­ent can­tons (mul­ti­centre re­search pro­ject), au­thor­isa­tion is re­quired from the eth­ics com­mit­tee which is re­spons­ible at the site of activ­ity of the pro­ject co­ordin­at­or (the lead com­mit­tee).

3 In or­der to as­sess wheth­er the pro­fes­sion­al and op­er­a­tion­al re­quire­ments are ful­filled in oth­er can­tons, the lead com­mit­tee shall seek the opin­ion of the eth­ics com­mit­tees con­cerned. It shall be bound by their opin­ion.

4 Para­graphs 2 and 3 ap­ply mu­tatis mutandis to au­thor­isa­tion for the use in ac­cord­ance with Art­icle 34 of bio­lo­gic­al ma­ter­i­al and health-re­lated per­son­al data of which fur­ther use is made or which are col­lec­ted ac­cord­ing to a stand­ard pro­tocol, but in dif­fer­ent can­tons.

Art. 48 Official measures  

1 If the safety or health of the per­sons con­cerned is at risk, the eth­ics com­mit­tee may re­voke or sus­pend its au­thor­isa­tion or make the con­tinu­ation of the re­search pro­ject sub­ject to ad­di­tion­al con­di­tions.

2 The eth­ics com­mit­tee may re­quest in­form­a­tion or doc­u­ment­a­tion from the hold­er of the au­thor­isa­tion. This must be provided or made avail­able free of charge.

3 The com­pet­ent fed­er­al and can­ton­al au­thor­it­ies re­tain the right to take meas­ures.

4 The au­thor­it­ies and eth­ics com­mit­tees shall keep each oth­er in­formed and co­ordin­ate their meas­ures.

Art. 49 Procedure  

1 The doc­u­ments for the au­thor­isa­tion and no­ti­fic­a­tion pro­ced­ures, and for re­port­ing and su­per­vi­sion, shall be sub­mit­ted to the can­ton­al in­form­a­tion sys­tem re­ferred to in Art­icle 56a.12

1bis The Fed­er­al Coun­cil shall spe­cify re­quire­ments for the pro­ced­ure so as to en­sure con­sist­ent en­force­ment and the im­ple­ment­a­tion of na­tion­al and in­ter­na­tion­al reg­u­la­tions. It may stip­u­late that the sub­mis­sion of ap­plic­a­tions, cor­res­pond­ence and the pub­lic­a­tion of de­cisions must be ef­fected elec­tron­ic­ally.13

2 In par­tic­u­lar for re­search pro­jects in­volving bio­lo­gic­al ma­ter­i­al and ge­net­ic data in ac­cord­ance with Art­icle 32, or non-ge­net­ic health-re­lated per­son­al data in ac­cord­ance with Art­icle 33, it may spe­cify less strin­gent pro­ced­ur­al re­quire­ments.

3 Can­ton­al pro­ced­ur­al law oth­er­wise ap­plies.

12 Amended by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

13 In­ser­ted by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Art. 50 Right of appeal  

1 The pro­ced­ure for ap­peals against eth­ics com­mit­tee de­cisions is gov­erned by can­ton­al pro­ced­ur­al law and the gen­er­al pro­vi­sions con­cern­ing the ad­min­is­tra­tion of fed­er­al justice.

2 The ap­peal­ing party may not file an ap­peal based on sub­stant­ive in­ap­pro­pri­ate­ness.

Chapter 9 Research Ethics Committees

Art. 51 Duties  

1 With­in the frame­work of their re­spons­ib­il­it­ies un­der Chapter 8, eth­ics com­mit­tees shall as­sess wheth­er re­search pro­jects and the con­duct there­of com­ply with the eth­ic­al, leg­al and sci­entif­ic re­quire­ments of this Act. In par­tic­u­lar, they shall as­sess wheth­er the pro­tec­tion of the per­sons con­cerned is guar­an­teed.

2 They may ad­vise re­search­ers in par­tic­u­lar on eth­ic­al ques­tions and, if so re­ques­ted by the re­search­ers, com­ment on re­search pro­jects not sub­ject to this Act, and spe­cific­ally pro­jects car­ried out abroad.

Art. 52 Independence  

1 Eth­ics com­mit­tees shall ex­er­cise their du­ties in a pro­fes­sion­ally in­de­pend­ent man­ner, without be­ing sub­ject to in­struc­tions from the su­per­vis­ory au­thor­ity in this re­gard.

2 The mem­bers of eth­ics com­mit­tees shall dis­close their in­terests. Each eth­ics com­mit­tee shall main­tain a pub­licly ac­cess­ible re­gister of in­terests.

3 Mem­bers who are in­ter­ested parties shall not par­ti­cip­ate in the as­sess­ment and de­cision pro­ced­ures.

Art. 53 Composition  

1 Eth­ics com­mit­tees must be com­posed in such a way that they have the pro­fes­sion­al skills and ex­per­i­ence re­quired to dis­charge their du­ties. The mem­bers must in­clude:

a.
ex­perts in vari­ous dis­cip­lines, in par­tic­u­lar medi­cine, eth­ics and law; and
b.
at least one per­son rep­res­ent­ing pa­tients.14

2 Eth­ics com­mit­tees may call in ex­tern­al spe­cial­ists to serve as ex­perts.

3 The Fed­er­al Coun­cil shall en­act ad­di­tion­al reg­u­la­tions con­cern­ing the com­pos­i­tion of eth­ics com­mit­tees and the re­quire­ments to be ful­filled by their mem­bers. In do­ing so, it shall have re­gard to re­cog­nised in­ter­na­tion­al reg­u­la­tions.

14 Amended by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Art. 54 Organisation and financing  

1 Each can­ton shall des­ig­nate the eth­ics com­mit­tee re­spons­ible for its ter­rit­ory and ap­point the mem­bers there­of. It shall over­see the activ­it­ies of the eth­ics com­mit­tee.

2 Each can­ton has at most one eth­ics com­mit­tee. Sev­er­al can­tons may ap­point a joint eth­ics com­mit­tee or agree that one can­ton's eth­ics com­mit­tee is also to be re­spons­ible for oth­er can­tons.

3 The Fed­er­al Coun­cil may is­sue guidelines con­cern­ing the min­im­um num­ber of re­search pro­jects to be as­sessed by an eth­ics com­mit­tee per year. It shall first con­sult the can­tons.

4 Each eth­ics com­mit­tee shall have a sci­entif­ic sec­ret­ari­at. De­tails of the or­gan­isa­tion and work­ing meth­ods are to be pub­licly ac­cess­ible in by-laws.

5 The can­ton shall as­sure the fin­an­cing of the eth­ics com­mit­tee. It may make pro­vi­sion for the char­ging of fees.

Art. 55 Coordination and information  

1 The Fed­er­al Of­fice of Pub­lic Health (FOPH) is re­spons­ible for co­ordin­a­tion between eth­ics com­mit­tees and with oth­er su­per­vis­ory au­thor­it­ies. It may del­eg­ate this re­spons­ib­il­ity to third parties.

2 Eth­ics com­mit­tees shall re­port an­nu­ally to the FOPH on their activ­it­ies, in par­tic­u­lar on the type and num­ber of re­search pro­jects as­sessed and on the pro­cessing peri­ods.

3 The FOPH shall pub­lish a list of eth­ics com­mit­tees and in­form the pub­lic reg­u­larly about their activ­it­ies.

4 In con­sulta­tion with the eth­ics com­mit­tees and oth­er su­per­vis­ory au­thor­it­ies con­cerned, it may is­sue re­com­mend­a­tions for ap­pro­pri­ate har­mon­isa­tion of pro­ced­ures and of as­sess­ment prac­tice.

Chapter 10 Transparency and Data Protection

Art. 56 Registration  

1 Au­thor­ised clin­ic­al tri­als must be re­cor­ded in a pub­lic re­gistry. The Fed­er­al Coun­cil shall define the clin­ic­al tri­als in more de­tail and may spe­cify ex­emp­tions from man­dat­ory re­gis­tra­tion; in do­ing so, it shall be guided by re­cog­nised in­ter­na­tion­al reg­u­la­tions.15

2 It shall des­ig­nate the re­gistry, provide in­form­a­tion on ac­cess thereto and spe­cify the con­tent of re­gis­tra­tion, as well as no­ti­fic­a­tion re­quire­ments and the no­ti­fic­a­tion pro­ced­ure. In do­ing so, it shall have re­gard to re­cog­nised in­ter­na­tion­al reg­u­la­tions and if pos­sible take ex­ist­ing re­gis­tries in­to con­sid­er­a­tion.

3 It may:

a.
en­trust pub­lic- or private-law or­gan­isa­tions with the es­tab­lish­ment and man­age­ment of the re­gistry;
b.16
spe­cify that the res­ults of re­gistered re­search pro­jects must be pub­lished on a re­cog­nised plat­form.

15 Second sen­tence amended by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

16 Amended by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Art. 56a Cantonal information system 17  

1 The can­tons shall op­er­ate a shared in­form­a­tion sys­tem for the con­duct of au­thor­isa­tion and no­ti­fic­a­tion pro­ced­ures, the trans­mis­sion of re­ports and the su­per­vi­sion of re­search pro­jects.

2 The sys­tem shall con­tain data, in­clud­ing per­son­al data on ad­min­is­trat­ive or crim­in­al pro­ceed­ings and sanc­tions or on health, which is ne­ces­sary for the con­duct of au­thor­isa­tion and no­ti­fic­a­tion pro­ced­ures and for re­port­ing and su­per­vi­sion in ac­cord­ance with this Act.

3 The can­tons shall en­sure that the in­form­a­tion sys­tem is com­pat­ible with the Med­ic­al Devices In­form­a­tion Sys­tem of the Swiss Agency for Thera­peut­ic Products and with the European data­base on med­ic­al devices (Eu­damed).

4 The Fed­er­al Coun­cil may spe­cify that:

a.
the data re­ferred to in para­graph 2 con­cern­ing clin­ic­al tri­als with med­ic­al devices is to be auto­mat­ic­ally aligned with the Med­ic­al Devices In­form­a­tion Sys­tem of the Swiss Agency for Thera­peut­ic Products or with Eu­damed;
b.
any data re­ferred to in para­graph 2 which is not sens­it­ive is to be pub­lished with due pro­tec­tion of pro­fes­sion­al con­fid­en­ti­al­ity and trade secrets.

17 In­ser­ted by An­nex of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Art. 57 Duty of confidentiality  

Per­sons re­spons­ible for the en­force­ment of this Act have a duty to main­tain con­fid­en­ti­al­ity.

Art. 58 Processing of personal data  

In dis­char­ging their du­ties, eth­ics com­mit­tees and the oth­er en­force­ment bod­ies are en­titled to pro­cess per­son­al data. Sens­it­ive per­son­al data may be pro­cessed, in­so­far as this is ne­ces­sary.

Art. 59 Disclosure of data  

1 Where no con­flict­ing private in­terest of over­rid­ing im­port­ance ex­ists, data may be dis­closed to:

a.
the fed­er­al and can­ton­al agen­cies re­spons­ible for en­force­ment of this Act, and to pub­lic- or private-law or­gan­isa­tions and per­sons if they re­quire the data to ful­fil the du­ties as­signed to them un­der this Act;
b.
crim­in­al in­vest­ig­a­tion au­thor­it­ies if the data is re­quired to pro­sec­ute or pre­vent a felony or an of­fence un­der this Act.

2 Where no con­flict­ing private in­terest of over­rid­ing im­port­ance ex­ists, data may, in in­di­vidu­al cases, fol­low­ing a writ­ten re­quest, be dis­closed to:

a.
civil courts if the data is re­quired to judge a court case;
b.
crim­in­al courts and crim­in­al in­vest­ig­a­tion au­thor­it­ies if the data is re­quired to in­vest­ig­ate a felony or mis­de­mean­our.

3 Data which is of gen­er­al in­terest and relates to the ap­plic­a­tion of this Act may be pub­lished. The data sub­jects must not be iden­ti­fi­able.

4 In oth­er cases, data may be dis­closed to third parties as fol­lows:

a.
data not re­lat­ing to spe­cif­ic per­sons, provided that there is an over­rid­ing in­terest in this data be­ing made avail­able;
b.
per­son­al data, provided that the data sub­ject has giv­en writ­ten con­sent in each case.

5 Only the data which is re­quired for the pur­pose in ques­tion may be dis­closed.

6 The Fed­er­al Coun­cil shall reg­u­late the de­tails of the dis­clos­ure of data and the no­ti­fic­a­tion of the per­sons con­cerned.

Art. 60 Transmission of data to foreign authorities and international organisations  

1 Con­fid­en­tial data may only be trans­mit­ted to for­eign au­thor­it­ies and in­sti­tu­tions or to in­ter­na­tion­al or­gan­isa­tions if:

a.
this is re­quired by agree­ments un­der in­ter­na­tion­al law or res­ol­u­tions passed by in­ter­na­tion­al or­gan­isa­tions;
b.
this is ne­ces­sary to avert an im­min­ent danger to life or health; or
c.
this would en­able ser­i­ous of­fences un­der this Act to be ex­posed.

2 The Fed­er­al Coun­cil shall reg­u­late re­spons­ib­il­it­ies and the pro­ced­ures for ex­chan­ging data with for­eign au­thor­it­ies and in­sti­tu­tions and with in­ter­na­tion­al or­gan­isa­tions.

Art. 61 Evaluation  

1 The FOPH is re­spons­ible for as­sess­ing the ef­fect­ive­ness of this Act.

2 The Fed­er­al De­part­ment of Home Af­fairs shall re­port to the Fed­er­al Coun­cil on the res­ults of the eval­u­ation and sub­mit pro­pos­als for fur­ther ac­tion.

Chapter 11 Criminal Provisions

Art. 62 Misdemeanours  

1 Un­less a more ser­i­ous of­fence has been com­mit­ted un­der the Crim­in­al Code18, any per­son who wil­fully:

a.
con­ducts a re­search pro­ject without the au­thor­isa­tion of an eth­ics com­mit­tee or de­vi­at­ing from an au­thor­ised pro­tocol (Art. 45) and thereby en­dangers the health of the par­ti­cipants;
b.
con­ducts a re­search pro­ject as defined in Chapter 2, 3, 5 or 6 without ob­tain­ing the con­sent re­quired un­der this Act (Arts. 16, 17, 18 para. 3, Art. 22 paras. 1, 3 let. a and 4, Arts. 23, 24, 26, 28, 30, 36 paras. 1 and 2, 39 para. 1, 40);
c.19
of­fers, grants, de­mands or ac­cepts pay­ment or any oth­er non-cash ad­vant­age in ex­change for the hu­man body or parts there­of as such;
cbis.20
uses the hu­man body or parts there­of if they have been sub­ject to a pro­hib­ited act as spe­cified in let­ter c;
d.
con­ducts a re­search pro­ject de­signed to modi­fy prop­er­ties of the em­bryo or foetus for non-dis­ease-re­lated reas­ons (Art. 25);
e.
uses em­bry­os or foetuses from in­duced or spon­tan­eous abor­tions for a re­search pro­ject be­fore death has been de­term­ined (Art. 39 para. 3, Art. 40 para. 2)

shall be li­able to a cus­todi­al sen­tence not ex­ceed­ing three years or to a mon­et­ary pen­alty.

2 If the act is com­mit­ted for com­mer­cial gain, the pen­alty shall be a cus­todi­al sen­tence not ex­ceed­ing three years; this shall be com­bined with a mon­et­ary pen­alty.

3 If the act is com­mit­ted through neg­li­gence, the pen­alty shall be a mon­et­ary pen­alty not ex­ceed­ing 180 daily pen­alty units.

18 SR 311.0

19 Amended by An­nex No 2 of the FD of 19 June 2020 on the Ap­prov­al of the Coun­cil of Europe Con­ven­tion against Traf­fick­ing in Hu­man Or­gans and on its Im­ple­ment­a­tion, in force since 1 Feb. 2021 (AS 2020 6567; BBl 2019 5971).

20 In­ser­ted by An­nex No 2 of the FD of 19 June 2020 on the Ap­prov­al of the Coun­cil of Europe Con­ven­tion against Traf­fick­ing in Hu­man Or­gans and on its Im­ple­ment­a­tion, in force since 1 Feb. 2021 (AS 2020 6567; BBl 2019 5971).

Art. 63 Contraventions  

1 Any per­son who wil­fully or neg­li­gently:

a.
com­mits an of­fence as spe­cified in Art­icle 62 para­graph 1 let­ter a without the par­ti­cipants' health be­ing en­dangered;
b.
makes a pay­ment or provides any oth­er non-cash ad­vant­age to a per­son for par­ti­cip­a­tion in a re­search pro­ject with an ex­pec­ted dir­ect be­ne­fit, or de­mands or ac­cepts pay­ment or any oth­er non-cash ad­vant­age from a per­son for par­ti­cip­a­tion in a re­search pro­ject (Art. 14);
c.
makes fur­ther use of bio­lo­gic­al ma­ter­i­al or health-re­lated per­son­al data without the in­formed con­sent re­quired un­der this Act (Arts. 32, 33), in cases where the con­di­tions spe­cified in Art­icle 34 are not met and ap­pro­pri­ate au­thor­isa­tion has not been ob­tained from the re­spons­ible eth­ics com­mit­tee;
d.
trans­fers bio­lo­gic­al ma­ter­i­al or health-re­lated per­son­al data for non-re­search-re­lated pur­poses in the ab­sence of a leg­al basis or without the re­quis­ite con­sent (Art. 41)

shall be li­able to a fine.

2 A con­tra­ven­tion and the pen­alty for a con­tra­ven­tion be­come time-barred after five years.

Art. 64 Jurisdiction and administrative criminal law  

1 The can­tons have jur­is­dic­tion for the pro­sec­u­tion and judg­ment of of­fences.

2 Art­icles 6, 7 (of­fences com­mit­ted with­in a busi­ness) and 15 (for­gery of doc­u­ments, ob­tain­ing a false cer­ti­fic­ate by fraud) of the Fed­er­al Act of 22 March 197421 on Ad­min­is­trat­ive Crim­in­al Law ap­ply.

3 The com­pet­ent au­thor­it­ies shall in­form the FOPH of all judg­ments passed in ac­cord­ance with Art­icle 62 para­graph 1 let­ters b–cbis or Art­icle 63 para­graph 1 let­ter c on ac­count of an of­fence in­volving the hu­man body or parts there­of.22

21 SR 313.0

22 In­ser­ted by An­nex No 2 of the FD of 19 June 2020 on the Ap­prov­al of the Coun­cil of Europe Con­ven­tion against Traf­fick­ing in Hu­man Or­gans and on its Im­ple­ment­a­tion, in force since 1 Feb. 2021 (AS 2020 6567; BBl 2019 5971).

Chapter 12 Final Provisions

Art. 65 Implementing provisions  

1 The Fed­er­al Coun­cil shall en­act the im­ple­ment­ing pro­vi­sions.

2 In do­ing so, it shall con­sider the dif­fer­ent ex­tents to which in­di­vidu­al re­search areas and meth­ods in­volve risks to dig­nity and pri­vacy, in par­tic­u­lar when spe­cify­ing:

the sci­entif­ic re­quire­ments (Art. 10);
b.
any ex­emp­tions from li­ab­il­ity (Art. 19) and li­ab­il­ity cov­er­age re­quire­ments (Art. 20);
c.
the re­quire­ments for in­sur­ance and oth­er forms of cov­er­age (Art. 20);
d.
the pro­ced­ur­al re­quire­ments (Art. 49).
Art. 66 Amendment of current legislation  

Cur­rent le­gis­la­tion shall be amended as spe­cified in the An­nex.

Art. 67 Transitional provisions  

1 Au­thor­isa­tions gran­ted by can­ton­al eth­ics com­mit­tees for the con­duct of re­search pro­jects re­main val­id for the term of the au­thor­isa­tion.

2 If no au­thor­isa­tion, as defined in para­graph 1, has been gran­ted for a re­search pro­ject which is already un­der way when this Act comes in­to ef­fect, an ap­plic­a­tion for au­thor­isa­tion in ac­cord­ance with Art­icle 45 para­graph 1 let­ter a shall be sub­mit­ted to the re­spons­ible eth­ics com­mit­tee with­in six months after the com­mence­ment of this Act.

3 Au­thor­isa­tions for the waiver of pro­fes­sion­al con­fid­en­ti­al­ity in med­ic­al re­search re­main val­id for the term of the au­thor­isa­tion. If the au­thor­isa­tion has been gran­ted for an un­lim­ited term, an ap­plic­a­tion for au­thor­isa­tion in ac­cord­ance with Art­icle 45 para­graph 1 shall be sub­mit­ted to the re­spons­ible eth­ics com­mit­tee with­in a year of the com­mence­ment of this Act.

4 The Fed­er­al Coun­cil shall reg­u­late the re­gis­tra­tion un­der Art­icle 56 of re­search pro­jects which are in pro­gress when this Act comes in­to force.

Art. 68 Referendum and commencement  

1 This Act is sub­ject to an op­tion­al ref­er­en­dum.

2 The Fed­er­al Coun­cil shall de­term­ine the com­mence­ment date.

Com­mence­ment Date: 1 Janu­ary 201423

23 FCD of 20 Sept. 2013.

Annex

(Art. 66)

Amendment of current legislation

The federal acts below are amended as follows:

24 The amendments may be consulted under AS 2013 3215.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden